Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisors prior to making any investment decisions based on information on this website.
Let's take a look at the stocks I discussed during the week of July 11, 2005, and find out how they turned out! For the sake of this evaluation, I assume an equal $ amount invested in each stock and a buy and hold strategy. In practice, I recommend and employ an active investment strategy that involves selling poorly performing holdings quickly and completely, and selling appreciating stocks slowly and partially at targeted price appreciation levels. This difference would certainly affect performance and should be taken into consideration.
On July 11, 2005, I posted Arrhythmia Research Technology Research (HRT) on Stock Picks Bob's Advice when it was trading at $14.55. I have never owned any shares of this stock. HRT closed at $21.11 on November 17, 2006, for a gain of $6.56 or 45.1% since posting.
On November 3, 2006, Arrhythmia Research announced 3rd quarter 2006 results. Total revenue climbed 32% to $4.41 million from $3.34 million in the same quarter last year. Net income increased 94% to $510,000 from $263,000 and earnings per share jumped 90% to $.19/share up from $.10/share in the same quarter last year.
On July 13, 2005, I posted Resources Connection (RECN) on Stock Picks Bob's Advice when it was trading at $29.42. I do not own any shares of this stock. RECN closed at $29.75 on November 17, 2006, for a gain of $.33 or 1.1% since posting.
On September 27, 2006, RECN reported 1st quarter fiscal 2007 results. While total revenue did climb 10.4% to $165.1 million from $149.6 million in the same quarter last year, GAAP net income was $11 million or $.22/diluted share, down from $15.1 million or $.29/diluted share. This quarter was adversely affected by "SFAS 123", the "accounting pronouncement requiring the recognition of compensation expense related to employee stock option grants and employee stock purchases..." Non-GAAP net income, excluding the stock-based compensation expense worked out to $15.1 million or $.30/share. This still wasn't anything terrific to 'write home about' and for the purpose of this blog, I stay with GAAP results, and thus, we get a 'thumbs-down' on this earnings resut.
Finally, on July 15, 2005, I posted Cintas (CTAS) on Stock Picks Bob's Advice when the stock was trading at $44.00. Cintas closed at $43.47 on November 17, 2006. I do not own any shares of this stock. This represents a loss of $(.53)/share or (1.2)% since posting.
On September 20, 2006, Cintas announced 1st quarter 2007 results. Revenue increased 11% to $914.2 million from $823.5 million last year. Net income climbed to $85 million or $.53/share, up from $78.4 million or $.46/share in the same quarter last year. Analysts had been looking for $920.8 million in sales and earnings of $.51/share. So the company underperformed a bit on the revenue side but then exceeded expectations on the earnings side. A mixed bag on the expectations business but overall nice results for the quarter.
So how did I do for the week of July 11, 2005? Well, one of the stocks had a nice gain and the other two showed very small changes; one with a small gain and the other with a small loss. Averaging this performance gets us an average gain of 15% for the three stocks.
Thanks so much for stopping by and visiting! If you have any comments or questions, please feel free to drop me a line at bobsadviceforstocks@lycos.com or go ahead and leave your comments right on the blog. If you get a chance, please stop by and visit my Stock Picks Podcast site!
Have a great weekend!
Bob